Article info

Download PDFPDF
Letter
Anti-angiogenic effect of metformin in human liver carcinogenesis related to metabolic syndrome

Authors

  1. Correspondence to Professor Valérie Paradis, Department of Pathology, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris, 100 Boulevard du Général Leclerc, Clichy 92110, France; vparadis{at}teaser.fr
View Full Text

Citation

Cauchy F, Mebarki M, Albuquerque M, et al
Anti-angiogenic effect of metformin in human liver carcinogenesis related to metabolic syndrome

Publication history

  • Received May 29, 2015
  • Revised June 9, 2015
  • Accepted June 10, 2015
  • First published June 29, 2015.
Online issue publication 
August 07, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.